Webinar
On-Demand Webinar: From Pre-Approval Inspection (PAI) to Complete Response Letter (CRL). Watch Now →
On-Demand Webinar: From Pre-Approval Inspection (PAI) to Complete Response Letter (CRL). Watch Now →
Products
products
Regulatory Intelligence
Understand and act on global regulatory change.
Inspection Intelligence
Anticipate inspection focus and enforcement risk.
Site Intelligence
Evaluate site and supplier risk.
Post-market Intelligence
Detect product quality & safety signals.
platform & data
Redica App
Instant insights on the platform.
Integrated solutions
End-to-end connected intelligence.
API
Real-time, scalable data access.
Our Data
Globally-trusted quality data & insights.
Explore integrations
Solutions
by function
Quality Teams
Regulatory Compliance
Supply Chain
Regulatory Affairs
Digital IT Teams
by industry
Pharmaceutical
MedTech
Cosmetics
Supplements & OTC
Food
Financial Services
featured case study
How a Top 10 Pharma Company Transformed CMO and API Oversight
latest report
The New Rules of CMO-Sponsor Collaboration
Resources
resources by type
Assessments
Insights on inspections, risk, and compliance.
Blog
Evaluate readiness and compliance maturity.
Reports
Benchmark industry trends and best practices.
Webinars
Hear from industry leaders and Redica experts.
latest report
The New Rules of CMO-Sponsor Collaboration
Quick links
Document Store
Knowledge Center
Login
Contact us
Company
Login
book a demo
Login
book a demo
Home
/
Blog
/
Redica Responds
Redica Responds
Redica Responds: How Many GMP Inspections Have Resulted in a 483?
September 14, 2022
Redica Responds: Top Quality Systems Issues at Medical Device Sites
August 31, 2022
Redica Responds: Insights on Media Fill Enforcement Trends
August 24, 2022
Redica Responds: Deviation Investigation 483 Trends
August 17, 2022
Redica Responds: Clinical Investigators and Paper Record Controls
August 10, 2022
Redica Responds: Cleaning Validation 483 Observations
August 3, 2022
Redica Responds: How Many Change Control 483s Over the Last Ten Years?
July 20, 2022
Redica Responds: Contamination Control 483s
July 13, 2022
Redica Responds: How Can I Compare Enforcement Histories for CMO Sites?
July 6, 2022
Redica Responds: What are the Top 483 Observations Involving Medical Device Postmarket Reporting?
June 28, 2022
All tags
Red Flag Model
Redica
Redica AI
Redica App
Redica Data
Redica ID
Redica Responds
Redica Systems
Regulatory Affairs
Regulatory Compliance
Regulatory Compliance
Regulatory Intelligence
Regulatory Meetings
Regulatory Surveillance
remote assessments
Remote Audits
remote inspection
repeat observations
Report
Response Letter
RIMS
risk management
Roger Angarita
root cause
Senior Leadership
Simone Pitts
Small Pharma
smart combination products
smart devices
Smart Folders
smoke study
snowflake
South Korea
Spaces
SQA
SQA Annual Meeting
Sterile
sterile manufacturing
sterility testing
Supplements
Supplier Agreements
Supplier audits
Supply Chain
sustainable compliance
Swissmedic
Switzerland
TGA
Tianjin Darentang Jingwanhong
Tianjin Darentang Jingwanhong Pharmaceutical
TNTC
Transfer of Regulatory Obligations
Trends
UDI
UDI requirements
UGA
Ulrich Köllisch
usability
vaccine
VAI
Valerie Fenster
Veeva
Vendor Agreements
vendor monitoring
vendor quality
virtual inspection
visually clean
Warning Letter
Warning Letter
warning letters
Webinar
Webinars
WFI
WHO
Previous
4 / 4
